Home About Us Services Our Network Therapeutic Areas Alliance and Partner FAQ Training
Case Study
Phase III - Oncology Ongoing Project
A Global Clinical Research Organization

 

Inoperable Gastric Cancer Phase III Study

  • UK based sponsor’s first study in India. High screen failures in the study which was unexpected and slow subject recruitment in almost 40 sites throughout in India.
  • Total Patient Recruitment Required – 740
  • Selected sites (40 sites) couldn't meet target timeline in 6 months.


D2L Solution

  • Provided Additional 12 more sites in one month
  • EC approvals process completed within a month
  • Pre-screening potential subjects
  • Conducted camps


Client Benefit

  • 150 subjects recruited in three months
  • Target Recruitment (50 more) will be achieved by Dec 2009

 

<< Back to Casestudy List
Casestudy | Career | Clientele | News | Contact Us
NEWS & MEDIA
InterVein Labs, D2L Pharma join hands
read more..

D2L-SMO at International Level Career Development Seminar for Biological Science Students held at Convention Centre, Kattankulathur, SRM University, Chennai
read more..

D2L-SMO to be present in the 16th International Seminar on "Global Clinical Trial Management and Logistics" organized by World Courier
read more..

D2L-SMO & Intervein Labs to be present at the DIA 44th Annual Meeting held on 22nd -26th June 2008 in Boston Convention & Exhibition Center, Boston
read more..

All rights reserved 2008 ©D2L-SMO   |  Terms and Conditions  |  Privacy Policy  |  Disclaimer      
Phone : 91 - 80 - 3245 0009 / 41743601
Fax : +91-80-41534831
Email : info@d2lpharma.com